A Sustained Release Cysteamine Microsphere/Thermoresponsive Gel Eyedrop for Corneal Cystinosis Improves Drug Stability published October 2021 in the Drug Delivery and Translational Research Journal by Morgan Fedorchak, PhD, and Ken Nischal, MD, FRCO, University of Pittsburgh, Pittsburgh, Pennsylvania.
DYNC1LI2 Regulates Localization of the Chaperone-Mediated Autophagy Receptor LAMP2A and Improves Cellular Homeostasis in Cystinosis published October 2021 in the Journal of Autophagy by Sergio Catz, PhD, The Scripps Research Institute, La Jolla, California.
Arginine-Selective Modulation of the Lysosomal Transporter PQLC2 through a Gate-Tuning Mechanism published August 2021 in the PNAS Journal (Proceedings of the National Academy of Sciences of the United States), by Bruno Gasnier, PhD, Paris-Descartes University, Paris France.
A Leptin Receptor Antagonist Attenuates Adipose Tissue Browning and Muscle Wasting in Infantile Nephropathic Cystinosis-Associated Cachexia published July 2021 in Cells Journal by Robert H. Mak, MD, PhD, Rady Children’s Hospital, University of California, San Diego.
Targeting Interleukin-1 for Reversing Fat Browning and Muscle Wasting in Infantile Nephropathic Cystinosis published June 2021 in the Journal of Cachexia, Sarcopenia, and Muscle by Robert H. Mak, MD, PhD, Rady Children’s Hospital, University of California, San Diego.
Non-Invasive Intradermal Imaging of Cystine Crystals in Cystinosis published March 2021 in the PLOS One (Public Library of Science Journal) by Stéphanie Cherqui, PhD, University of California, San Diego.
Clinical Trial Readiness Study of Distal Myopathy and Dysphagia in Nephropathic Cystinosis published July 2020 in the Muscle & Nerve Journal by Reza Seyedsadjadi, MD, and Florian Eichler, MD, Massachusetts General Hospital, Boston, Massachusetts.
Protection of Cystinotic Mice by Kidney-Specific Megalin Ablation Supports an Endocytosis-Based Mechanism for Nephropathic Cystinosis Progression published June 2020 in the Journal of the American Society of Nephrology by Pierre Courtoy MD, PhD, and Christophe Pierreux, PhD., de Duve Institute, Brussels, Belgium.
Cell-Based Phenotypic Drug Screening Identifies Luteolin as Candidate Therapeutic for Nephropathic Cystinosis published July 2020 in the Journal of the American Society of Nephrology by Laura Rita Rega, PhD, and Francesco Emma, MD, Bambino Gesù Childrens Hospital, Rome, Italy.
Mitochondrial Dynamics of Proximal Tubular Epithelial Cells in Nephropathic Cystinosis, published January 2020 in the International Journal of Molecular Sciences by Francesco Bellomo, PhD, and Francesco Emma, MD, Bambino Gesù Childrens Hospital, Rome, Italy
Bone Disease in Nephropathic Cystinosis: Beyond Renal Osteodystrophy, published March 2020 in the International Journal of Molecular Sciences by Justine Bacchetta, MD, PhD, and Irma Machuca-Gayet, PhD, Hospices Civils de Lyon, Lyon, France.
Use of Human Induced Pluripotent Stem Cells and Kidney Organoids to Develop a Cysteamine/mTOR Inhibition Combination Therapy for Cystinosis, published March 2020 in Journal of the American Society of Nephrology by Alan J. Davidson, PhD, Teresa Holm, MD, PhD, and Jennifer Hollywood, PhD, University of Auckland, New Zealand.
Visual and Verbal Learning and Memory in Cystinosis, published June 2019 in Brain and Cognition Journal by Doris A. Trauner, MD, University of California, San Diego.
Interaction Between Galectin-3 and Cystinosin Uncovers a Pathogenic Role of Inflammation in Kidney Involvement of Cystinosis, published April 2019 in Kidney International by Stéphanie Cherqui, PhD, University of California, San Diego, in collaboration with Corinne Antignac, MD, PhD, Imagine Institute, Paris, France, Sergio Catz, PhD, The Scripps Research Institute, La Jolla, California, and Robert Mak, MD, PhD, University of California, San Diego and Tatiana Lobry, University of California, San Diego.
The Aminoglycoside Geneticin Permits Translational Readthrough of the CTNS W138X Nonsense mutation in Fibroblasts from Patients with Nephropathic Cystinosis, published in February 2019 in Pediatric Nephrology by Paul Goodyer, MD, The Research Institute of the McGill University, Montreal, Canada
Chaperone-Mediated Autophagy Upregulation Rescues Megalin Expression and Localization in Cystinotic Proximal Tubule Cells, published February 2019 in Frontiers in Endocrinology by Sergio Catz, PhD, The Scripps Research Institute, La Jolla, California
Intrinsic Bone Defects in Cystinotic Mice, published January 2019 in The American Journal of Pathology by Anna Taranta, PhD, Department of Nephrology and Urology, Division of Nephrology, Bambino Gesù Children’s Hospital, Rome, Italy.
A Genetic Screen for Investigating the Human Lysosomal Cystine Transporter, Cystinosin, Published online February 21, 2018 in Scientific Reports, by Anand Kumar Bacchawat, PhD, FNA, FNASc, FASc, Indian Institute of Science and Education Research Mohali, Punjab, India.
Potential Use of Stem Cells as a Therapy for Cystinosis, Published online May 22, 2018 in Pediatric Nephrology, by Stéphanie Cherqui, PhD, and Celine J. Rocca, PhD, Department of Pediatrics, Division of Genetics, University of California, San Diego.
Impaired Autophagy Bridges Lysosomal Storage Disease and Epithelial Dysfunction in the Kidney, Published January 2018 in Nature Communications, by Olivier Devuyst, MD, PhD and Alessandro Luciani, PhD, University of Zürich, Switzerland
All-Purpose HSCs, Published November 30, 2017 in BIOCENTURY Innovations Journal highlights Dr. Stéphanie Cherqui’s stem cell research at the University of California San Diego.
Transplantation of Wild-Type Mouse Hematopoietic Stem and Progenitor Cells Ameliorates Deficits in a Mouse Model of Friedreich’s Ataxia, Published November 2017 in Science Translational Medicine by Stéphanie Cherqui, PhD, University of California, San Diego.